Plinabulin is a novel selective immunoregulatory microtubule binder (SIMBA) that triggers the release of the immune defense protein GEF-H1 to induce the maturation of APCs and DCs, enhance the cross-presentation of tumor antigens to CD8+ T cells, and activate effector T cells to target tumor cells. Here, CD8A is linked to neoplasm.